Rasburicase for Hyperuricemia

NCT00290992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Nutritional and Metabolic Diseases

Interventions

DRUG: rasburicase (SR29142)

Sponsor

Sanofi